Drugs / Peg-Ada
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ADAGEN | — | 1990-03-21 | fda.gov ↗ |
Trials 0
Also used as a comparator or background therapy in 4 trials
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG-ADA | “pegademase bovine (PEG-ADA) Enzyme Replacement Therapy (ERT) is discontinued at Day+30 (-3/+15) after the transplant” NCT03765632 ↗4“pegademase bovine (PEG-ADA) Enzyme Replacement Therapy (ERT) is discontinued at Day+30 (-3/+15) after the transplant” NCT02999984 ↗ “pegademase bovine (PEG-ADA) enzyme replacement therapy (ERT)” NCT01852071 ↗ |
| Known as | pegademase bovine | “pegademase bovine (PEG-ADA) Enzyme Replacement Therapy (ERT) is discontinued at Day+30 (-3/+15) after the transplant” NCT03765632 ↗2“pegademase bovine (PEG-ADA) Enzyme Replacement Therapy (ERT) is discontinued at Day+30 (-3/+15) after the transplant” NCT02999984 ↗ “pegademase bovine (PEG-ADA) enzyme replacement therapy (ERT)” NCT01852071 ↗ |
| Modality | Protein / enzyme biologic | “Peg-Ada enzyme replacement therapy” NCT01380990 ↗ |